Under the agreement, Valneva will conduct an R&D program on behalf of GSK to develop and improve upstream processes ... Valneva is incorporated in Lyon, France, listed on Euronext-Paris and the Vienna stock exchange and has …
An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data …
GlaxoSmithKline Consumer Healthcare has consolidated its global agency roster to nine shops across advertising, digital, content, PR, expert marketing and shopper marketing to support its leading brands, such as Sensodyne and …
LONDON (Reuters) - Britain's Orchard Therapeutics, which has already raised more than $140 million to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of GlaxoSmithKline rare …
GlaxoSmithKline’s (NYSE:GSK) fourth quarter earnings were less than stellar as the British drugmaker’s profits were squeezed by legal charges for diabetes drug Avandia and declining sales of its products due to generic competition. …
wrote to the Bombay Stock Exchange (BSE): “This is to notify that the company (GSKCH) notes the announcement by GlaxoSmithKline plc (GSK) of its intent to carry out a strategic review of GSK’s Horlicks and its other consumer …
Shares of GlaxoSmithKline stock rose 1.3% in Monday trading. --CNN's Terry Frieden and CNN's Medical Unit contributed to this report